The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 28, 2018
Filed:
Nov. 06, 2015
Applicant:
Universite Laval, Quebec, CA;
Inventors:
Jean-Pierre Julien, Quebec, CA;
Vivek Swarup, Quebec, CA;
Assignee:
UNIVERSITE LAVAL, Quebec, CA;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 49/00 (2006.01); G01N 33/53 (2006.01); A61B 5/00 (2006.01); A61K 39/395 (2006.01); A61K 39/00 (2006.01); A61K 38/00 (2006.01); C07K 14/00 (2006.01); C07K 7/00 (2006.01); G01N 33/68 (2006.01); C12Q 1/6883 (2018.01); G01N 33/50 (2006.01); C12N 15/113 (2010.01); A61K 31/58 (2006.01); A61K 31/7088 (2006.01); A01K 67/027 (2006.01); C07K 14/47 (2006.01); C12N 15/85 (2006.01); C07K 16/18 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6896 (2013.01); A01K 67/0275 (2013.01); A61K 31/58 (2013.01); A61K 31/7088 (2013.01); C07K 14/4702 (2013.01); C07K 16/18 (2013.01); C12N 15/113 (2013.01); C12N 15/8509 (2013.01); C12Q 1/6883 (2013.01); G01N 33/502 (2013.01); A01K 2217/052 (2013.01); A01K 2227/105 (2013.01); A01K 2267/0312 (2013.01); A01K 2267/0318 (2013.01); C07K 2317/76 (2013.01); C12N 2310/14 (2013.01); C12Q 2600/112 (2013.01); C12Q 2600/158 (2013.01); G01N 2333/4703 (2013.01); G01N 2333/4704 (2013.01); G01N 2500/00 (2013.01); G01N 2800/28 (2013.01); G01N 2800/2835 (2013.01); G01N 2800/50 (2013.01); G01N 2800/56 (2013.01);
Abstract
The present invention provides methods and uses for the diagnostic of a subject predisposed or suspected of developing a neurodegenerative disease or suffering from a neurodegenerative disease. The present invention also relates to methods and uses for identifying candidate compounds and to compounds for treating neurodegenerative disease. The present invention also relates to an animal model for neurodegenerative disease.